← Eichor
Study identifier: NCT03868150 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment

Condition: Postoperative Atrial Fibrillation  ·  Sponsor: Stanford University

PhasePhase 4
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Patients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are not inducible to AF will be treated with standard post-operative care. Patients will be monitored post-operatively to explore the value of intraoperative inducibility of AF to predict POAF and to evaluate whether the combination of intraoperative inducibility and precision amiodarone therapy is effective at reducing the incidence of POAF

This description comes directly from the study's public registry record.

Talk to the study team

Anson Lee, MD  ·  650-724-7500  ·  ansonlee@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Stanford UniversityStanford, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03868150